Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer

被引：0
|
作者：
Redmond-Craig Anderson
Erik M. Velez
Hossein Jadvar
机构：
[1] University of Southern California,Division of Nuclear Medicine, Department of Radiology, Keck School of Medicine
来源：
Molecular Imaging and Biology | 2022年 / 24卷
关键词：
Oligometastatic; Prostate; Cancer; Fluciclovine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：920 / 927
页数：7
相关论文
共 50 条
  • [1] Management Impact of Metachronous Oligometastatic Disease Identified on 18F-Fluciclovine (Axumin™) PET/CT in Biochemically Recurrent Prostate Cancer
    Anderson, Redmond-Craig
    Velez, Erik M.
    Jadvar, Hossein
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (06) : 920 - 927
  • [2] Incidence and Impact of Oligometastatic Disease Detected on 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer
    Anderson, Redmond-Craig
    Velez, Erik
    Jadvar, Hossein
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [3] Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using 18F-Fluciclovine PET/CT
    Miller, Matthew P.
    Kostakoglu, Lale
    Pryma, Daniel
    Yu, Jian Qin
    Chau, Albert
    Perlman, Eric
    Clarke, Bonnie
    Rosen, Donald
    Ward, Penelope
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (10) : 1596 - 1602
  • [4] The FALCON trial: Impact of 18F-fluciclovine PET/CT on clinical management choices for men with biochemically recurrent prostate cancer.
    Teoh, Eugene Jueren
    Bottomley, David M.
    Scarsbrook, Andrew
    Payne, Heather
    Afaq, Asim
    Bomanji, Jamshed
    Van As, Nick
    Chua, Sue
    Hoskin, Peter
    Chambers, Anthony
    Cook, Gary J.
    Warbey, Victoria S.
    Chau, Albert
    Ward, Penelope
    Miller, Matthew P.
    Stevens, Daniel J.
    Wilson, Lynn
    Gleeson, Fergus V.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [5] Negative 18F-Piflufolastat PET/CT, But Positive 18F-Fluciclovine PET/CT, in a Patient With Biochemically Recurrent Prostate Cancer
    Ulaner, Gary A.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (10) : 968 - 970
  • [6] 18F-Fluciclovine PET in Recurrent Prostate Cancer
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (04) : 17N - 17N
  • [7] PSA Level Predicts Positivity of 18F-Fluciclovine PET/CT in Patients with Biochemically Recurrent Prostate Cancer
    Sathianathen, Niranjan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 63 - 63
  • [8] PSA LEVEL PREDICTS POSITIVITY OF 18F-FLUCICLOVINE PET/CT IN PATIENTS WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER
    Sathianathen, Niranjan
    Genturk, Mehmet
    Salavati, Ali
    Konety, Badrinath
    Froelich, Jerry
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1162 - E1162
  • [9] PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer
    Crocerossa, Fabio
    Carbonara, Umberto
    Parekh, Jayashree
    Urdaneta, Alfredo
    Weprin, Samuel
    Damiano, Rocco
    Grob, Mayer B.
    Hampton, Lance J.
    Paul, Asit
    Autorino, Riccardo
    Cantiello, Francesco
    UROLOGIA INTERNATIONALIS, 2021, : 920 - 927
  • [10] PREDICTORS OF POSITIVE LESIONS IN 18F-FLUCICLOVINE (AXUMIN) PET/CT
    Hougen, Helen
    Mallak, Nadine
    Isharwal, Sudhir
    Kopp, Ryan
    Liu, Jen-Jane
    Hung, Arthur
    JOURNAL OF UROLOGY, 2020, 203 : E1103 - E1103
12345